Northrop Grumman Corporation

“Northrop Grumman is one of the few defense businesses with a structurally unassailable moat — sole-source positions on B-21 and Sentinel lock it into U.S. nuclear doctrine for decades, with a 30-year FCF ramp ahead as programs shift from money-losing development into high-margin production and sustainment. The business is not impaired; it is temporarily penalized by management's decision to accept below-cost fixed-price contracts that have destroyed $2B+ pre-tax. FCF is accelerating, the backlog is $85B+, and defense tailwinds are structural. However, at 16.3x trailing earnings with ~7% base-case annual returns, the stock is fairly priced rather than cheap — offering modest alpha and limited margin of safety against balance sheet complexity ($17B debt, negative tangible book) or further program write-downs. TRACK with intent to initiate a small tranche on any pullback toward $450-480 or on confirmed B-21 margin normalization.”